Provided by Tiger Trade Technology Pte. Ltd.

CytomX Therapeutics

3.81
-0.4800-11.19%
Post-market: 3.970.1599+4.20%17:29 EST
Volume:2.85M
Turnover:11.16M
Market Cap:645.55M
PE:15.90
High:4.28
Open:4.24
Low:3.76
Close:4.29
52wk High:4.62
52wk Low:0.4000
Shares:169.44M
Float Shares:113.00M
Volume Ratio:1.48
T/O Rate:2.52%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.2396
EPS(LYR):0.3774
ROE:66.76%
ROA:9.78%
PB:6.01
PE(LYR):10.09

Loading ...

Vera Therapeutics Appoints James R. Meyers to Board of Directors

Reuters
·
Nov 27

CytomX Therapeutics to Present at Upcoming December Investor Conferences

GlobeNewswire
·
Nov 25

Cantor Fitzgerald Remains a Buy on CytomX Therapeutics (CTMX)

TIPRANKS
·
Nov 20

Stock Track | CytomX Therapeutics Plummets 7.80% as Analysts Slash 2026 Forecasts

Stock Track
·
Nov 13

Stock Track | CytomX Therapeutics Plummets 7.80% as Analysts Slash Revenue and Earnings Forecasts

Stock Track
·
Nov 13

Stock Track | CytomX Therapeutics Plunges 5.20% Pre-market Following Dramatic Analyst Forecast Downgrade

Stock Track
·
Nov 13

Stock Track | CytomX Therapeutics Plunges 5.20% Pre-market Following Analysts' Dramatic Forecast Downgrade

Stock Track
·
Nov 13

CytomX Therapeutics to Present at the Jefferies London Healthcare Conference

GlobeNewswire
·
Nov 13

Analysts Just Shaved Their CytomX Therapeutics, Inc. (NASDAQ:CTMX) Forecasts Dramatically

Simply Wall St.
·
Nov 13

CytomX Therapeutics Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Nov 11

CytomX CEO Sean A. McCarthy Reports Sale of Common Shares

Reuters
·
Nov 11

Cantor Fitzgerald Remains a Buy on CytomX Therapeutics (CTMX)

TIPRANKS
·
Nov 11

Stock Track | CytomX Therapeutics Plunges 6.92% Pre-Market Following Disappointing Q3 Earnings

Stock Track
·
Nov 07

Stock Track | CytomX Therapeutics Plunges 6.92% Pre-market Following Disappointing Q3 Earnings

Stock Track
·
Nov 07

Stock Track | CytomX Therapeutics Plunges 7.16% After Q3 Earnings Miss and Revenue Shortfall

Stock Track
·
Nov 07

Cancer immunotherapy firm CytomX's Q3 revenue falls

Reuters
·
Nov 07

CytomX Therapeutics reports Q3 EPS (9c), consensus (4c)

TIPRANKS
·
Nov 07

Stock Track | CytomX Therapeutics Plunges 5.49% After-Hours on Q3 Earnings Miss and Revenue Shortfall

Stock Track
·
Nov 07

CytomX Therapeutics Q3 Revenue USD 5.963 Million Vs. IBES Estimate USD 11.6 Million

Reuters
·
Nov 07

CytomX Therapeutics Q3 EPS $(0.09) Misses $(0.05) Estimate, Sales $5.963M Miss $11.625M Estimate

Benzinga
·
Nov 07